GOTTWALD WILLIAM M sold $34K of TG (indirect holdings)

GOTTWALD WILLIAM M sold 4,197 indirectly-held shares of TREDEGAR CORP (TG) at an average of $8.02 ($8.00–$8.02) across 2 trades over 2026-05-28 to 2026-05-29.

Original reporting
SEC EDGAR · GOTTWALD WILLIAM M
Published Jun 1, 2026, 6:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 3:47 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TG
Bearish
high confidence
Mentioned
$TG
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TGBearishLow
01

Why it matters

The disclosed sale is modest and unlikely to move the stock materially.

02

Market read

Small insider sale with limited price impact; primarily informational.

03

What to watch

Insider still holds ~457k shares, representing a sizable stake.

Relevance 3/10Novelty 3/10Timing: filing after market close

Background

SEC Form 4 filing discloses insider transactions; investors monitor for material changes.

Company-level read

Ticker impact

$TGBearishHigh confidence
Context

Form 4 shows insider sold ~4.2k shares for $33.7k, reducing his stake.

Expected impact

likely modest pressure as market prices in the sale

Evidence & confidence

Sale size is small relative to float; no 10b5‑1 plan; typical short‑term impact is limited.

Market effects

None significant for the broader sector.

U.S. equity market only; no regional effect.

Minimal.

Counterpoint

The sale could be routine portfolio rebalancing, not a bearish signal.

Key entities

  • Gottwald William M

    10% owner of Tredegar Corp who sold 4,197 shares.

  • Tredegar Corp

    Medical device manufacturer listed as TG.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TGMed

TREDEGAR REPORTS THIRD QUARTER 2026 RESULTS

TREDEGAR CORP (TG) filed an SEC Form 8-K — Results of Operations and Financial Condition. TREDEGAR REPORTS THIRD QUARTER 2026 RESULTS • Net loss from continuing operations of $(2.8) million, or $(0.08) per diluted share, for the third quarter of 2026 compared to net income from continuing operations $7.1 million, or $0.20 per diluted share, for the third quarter of 20

$TGMed

Tredegar Soars on Q2 Financials

Tredegar Corp (NYSE:TG) reported Q2 2026 results for the period ended June 30, 2026. Net income from continuing operations rose to $6.0 million, or $0.17 per diluted share, from $1.8 million, or $0.05 per share, in Q2 2025. Excluding special items, net income was $6.4 million, or $0.18 per share. Aluminum Extrusions EBITDA was $14.5 million versus $9.3 million in Q2 2025.

$TGMed

TREDEGAR REPORTS SECOND QUARTER 2026 RESULTS

TREDEGAR CORP (TG) filed an SEC Form 8-K — Results of Operations and Financial Condition. TREDEGAR REPORTS SECOND QUARTER 2026 RESULTS • Increased second quarter 2026 results, with net income from continuing operations of $6.0 million, or $0.17 per diluted share, for the second quarter of 2026 compared to $1.8 million, or $0.05 per diluted share, for the second quarte